NCT00558883View on ClinicalTrials.gov

AI(I)DA Acarbose and the Subclinical Inflammation

PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

May 31, 2007

Conditions
Type 2 Diabetes MellitusSubclinical Inflammation
Interventions
DRUG

acarbose

oral application

Trial Locations (1)

01187

GWT-TUD GmbH; Centre for Clinical Studies, Dresden

All Listed Sponsors
collaborator

Technische Universität Dresden

OTHER

collaborator

Diakonissen Krankenhaus Dresden, Germany

UNKNOWN

collaborator

University of Regensburg

OTHER

lead

GWT-TUD GmbH

OTHER

NCT00558883 - AI(I)DA Acarbose and the Subclinical Inflammation | Biotech Hunter | Biotech Hunter